Clinical Trial Update: U87 CAR-T in Patients With Advanced Head and Neck Tumors [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial is evaluating U87 CAR-T therapy in patients with advanced head and neck tumors, including nasopharyngeal cancer, and is currently recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Nasopharyngeal Cancer

Drugs mentioned

• U87 CAR-T

Snippet

Sponsor: Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd | Conditions: Nasopharynx Cancer, Head and Neck Cancer | Phase 1 | Status: RECRUITING